SI-BONE Inc (SIBN)

• Market cap: $700M
• 1 day: -1.36%
• 5 days: 20.77%
• 1 month: 20.59%
• 3 months: 30.29%
• 6 months: -2.45%
• Year to date: 19.81%
• 1 year: -11.18%
• 5 years: -23.30%
• 10 years: -16.80%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Employees: 344

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

41% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 37

6% more capital invested

Capital invested by funds: $537M [Q2] → $572M (+$34.8M) [Q3]

6% more call options, than puts

Call options by funds: $3.72M | Put options by funds: $3.52M

5% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 22

2.66% less ownership

Funds ownership: 100.74% [Q2] → 98.09% (-2.66%) [Q3]

3% less funds holding

Funds holding: 137 [Q2] → 133 (-4) [Q3]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $18 8% upside
• Avg. target: $18.50 11% upside
• High target: $19 14% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Needham David Saxon 34% 1-year accuracy 21 / 62 met price target	14% upside $19	Buy Reiterated	13 Jan 2025
Truist Securities Samuel Brodovsky 85% 1-year accuracy 11 / 13 met price target	8% upside $18	Buy Maintained	13 Nov 2024